973
Participants
Start Date
April 30, 2004
Primary Completion Date
October 31, 2005
Study Completion Date
October 31, 2005
Solifenacin succinate
oral
Placebo
oral
Antwerp
Bruges
Brussels
Ghent
Hasselt
Kortrijk
Leuven
Liège
Ostrava
Prague
Zlín
Al Mansurah
Lille
Lomme
Mulhouse
Nantes
Nîmes
Paris
Aichach
Bad Neuenaher
Bamberg
Bautzen
Berlin
Dierdorf
Dülmen
Düsseldorf
Frankfurt
Henningsdorf
Munich
Neustadt
Nuremberg
Planegg
Athens
Crete
Ioannina
Budapest
Nyíregyháza
Pécs
Szeged
Tatabánya
Bari
Catanzaro
Cinisello Balsamo
Magenta
Modena
Perugia
Turin
Udine
Bydgoszcz
Wroclaw
Abrantes
Lisbon
Porto
Santarém
Moscow
Banska Bysterica
Martin
Žilina
Barcelona
Coaña
Córdoba
Madrid
Mérida
San Cristóbal de La Laguna
Seville
Birmingham
Cottingham
Croydon
Edinburgh
Huntingdon
London
Manchester
Oldham
Stoke-on-Trent
Sunderland
Torbay
Welwyn Garden City
Worthing
Lead Sponsor
Astellas Pharma Inc
INDUSTRY